"Seven months after the FDA placed two trials of S
Post# of 148190
(Total Views: 730)
Posted On: 05/09/2023 12:45:17 PM
"Seven months after the FDA placed two trials of Salarius Pharmaceuticals’ lead asset seclidemstat in rare cancer indications on hold in the wake of a patient death, the regulator has given the green light for one of the studies to proceed.."
https://www.fiercebiotech.com/biotech/salariu...ient-death
So, they had a patient DIE yet the FDA lets them proceed after 7 months.
How long has CYDY had the hold?
https://www.fiercebiotech.com/biotech/salariu...ient-death
So, they had a patient DIE yet the FDA lets them proceed after 7 months.
How long has CYDY had the hold?
(7)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼